Dr. DEVOS MD
ActiveSummary
Dr. DEVOS MD has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€42,497) and a net result of -€4,762. Equity remains stable across the filed financial years (±1.6% per year). Its solvency ranks better than 5% of 780 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
financial year 2025 · full format · 28 days late
2025
19-11
NBB filing
Annual accounts filed
financial year 2024 · full format · 111 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €2,618 ▲34.9%
Operating result €2,713, net result €2,618, both a record.
30-09
NBB filing
Annual accounts filed
financial year 2023 · micro format · 61 days late
2023
31-12
Financial
Back to profitnet €1,940
Net result €1,940 after 2 loss-making years.
28-12
NBB filing
Annual accounts filed
financial year 2022 · full format · 150 days late
2022
30-09
NBB filing
Annual accounts filed
financial year 2021 · full format · 61 days late
2021
26-10
NBB filing
Annual accounts filed
financial year 2020 · full format · 87 days late
2020
31-12
Financial
Back to profitnet €1,292
Net result €1,292 after 2 loss-making years.
30-11
NBB filing
Annual accounts filed
financial year 2019 · full format · 122 days late
2019
16-07
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
24-09
NBB filing
Annual accounts filed
financial year 2017 · full format · 55 days late
2017
27-11
NBB filing
Annual accounts filed
financial year 2016 · full format · 119 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 16 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.